Alessandro Nervegna will be appointed as new Chief Executive Officer of Ferrero Core, driving growth of the Group's core categories.…
Chesterbrook, PA, March 03, 2026 (GLOBE NEWSWIRE) -- Persevere Therapeutics, Inc. (“Persevere”), a Delaware-incorporated, clinical-stage oncology biotechnology company, today announced…
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical…
TORONTO, March 2, 2026 /PRNewswire/ -- 3iQ Corp. ("3iQ"), a global pioneer in institutional digital asset investment solutions, is pleased…
LEHI, Utah, March 2, 2026 /PRNewswire/ -- Halia Therapeutics, a clinical-stage biopharmaceutical company advancing therapies grounded in human biology, today…
Bitmine has 3,040,483 staked ETH, representing $6.0 billion at $1,976 per ETH; MAVAN staking solution on track to launch Q1…
-- -18.8% placebo-adjusted difference in BMI reduction achieved in all patients (N=142) at 52 weeks, including 12 Japanese patients and…
SEOUL, South Korea, Feb. 27, 2026 /PRNewswire/ -- Medit, a global provider of digital dentistry solutions, today announced that the…
February 27, 2026 09:15 ET | Source: SEALSQ Geneva, Switzerland, Feb. 27, 2026 (GLOBE NEWSWIRE) -- SEALSQ Corp (NASDAQ: LAES)…
February 27, 2026 09:02 ET | Source: Veeco Instruments Inc. PLAINVIEW, N.Y., Feb. 27, 2026 (GLOBE NEWSWIRE) -- Veeco Instruments…